These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11115827)

  • 1. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.
    Chariyalertsak S; Sirikulchayanonta V; Mayer D; Kopp-Schneider A; Fürstenberger G; Marks F; Müller-Decker K
    Gut; 2001 Jan; 48(1):80-6. PubMed ID: 11115827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma.
    Wu GS; Wang JH; Liu ZR; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.
    Hayashi N; Yamamoto H; Hiraoka N; Dono K; Ito Y; Okami J; Kondo M; Nagano H; Umeshita K; Sakon M; Matsuura N; Nakamori S; Monden M
    Hepatology; 2001 Oct; 34(4 Pt 1):638-50. PubMed ID: 11584358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells.
    Nzeako UC; Guicciardi ME; Yoon JH; Bronk SF; Gores GJ
    Hepatology; 2002 Mar; 35(3):552-9. PubMed ID: 11870367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA
    Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.
    Sirica AE; Lai GH; Endo K; Zhang Z; Yoon BI
    Semin Liver Dis; 2002 Aug; 22(3):303-13. PubMed ID: 12360423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclooxygenase-2 antisense vector on proliferation of human cholangiocarcinoma cells.
    Wu GS; Zou SQ; Wu XY; Qiu FZ
    Chin Med Sci J; 2004 Jun; 19(2):89-92. PubMed ID: 15250241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
    Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
    Surrey LF; Frank R; Zhang PJ; Furth EE
    Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
    Wu T; Han C; Lunz JG; Michalopoulos G; Shelhamer JH; Demetris AJ
    Hepatology; 2002 Aug; 36(2):363-73. PubMed ID: 12143044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma.
    Qiu DK; Ma X; Peng YS; Chen XY
    World J Gastroenterol; 2002 Oct; 8(5):815-7. PubMed ID: 12378621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
    Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
    World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-1 and -2 in human breast cancer.
    Yoshimura N; Sano H; Okamoto M; Akioka K; Ushigome H; Kadotani Y; Yoshimura R; Nobori S; Higuchi A; Ohmori Y; Nakamura K
    Surg Today; 2003; 33(11):805-11. PubMed ID: 14605950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kupffer cell-derived cyclooxygenase-2 regulates hepatocyte Bcl-2 expression in choledocho-venous fistula rats.
    Souto EO; Miyoshi H; Dubois RN; Gores GJ
    Am J Physiol Gastrointest Liver Physiol; 2001 May; 280(5):G805-11. PubMed ID: 11292587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bile from patient with transduodenal sphincteroplasty on the growth of human cholangiocarcinoma cell line.
    Wu G; Zou S; Liu Z; Qiu F
    Chin Med Sci J; 2004 Mar; 19(1):72. PubMed ID: 15104232
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclooxygenase-2 and prostaglandin signaling in cholangiocarcinoma.
    Wu T
    Biochim Biophys Acta; 2005 Jul; 1755(2):135-50. PubMed ID: 15921858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.